Literature DB >> 2068914

Early ultrastructural effects of gentamicin cochleotoxicity.

J C De Groot1, E H Huizing, J E Veldman.   

Abstract

Ultrastructural changes in the cochlear hair cells during the early stages of gentamicin intoxication were investigated after tri-aldehyde primary fixation and OSO4/K4Ru(CN)6 post-fixation. In cochleas treated for 5, 10 and 15 days with gentamicin the individual outer hair cells (OHC1, OHC2 and OHC3) were randomly affected. Degeneration of the inner hair cells was not observed at this stage. Ultrastructurally, the earliest identifiable changes were an increase in lysosomes, proliferation of the endoplasmic reticulum, and formation of Hensen's bodies. This was followed by dilatation of the endoplasmic reticulum and the nuclear envelope, giving rise to extensive cytoplasmic vacuolation. These results demonstrate that gentamicin-induced changes primarily involve the cell's synthetic apparatus. All further intracellular changes occur at a much later stage and are therefore to be considered secondary events.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2068914     DOI: 10.3109/00016489109137387

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  3 in total

1.  A new immunohistochemical method for the detection of gentamicin in inner ear fluid compartments.

Authors:  M Mihelic-Rapp; W Giebel
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

2.  Functional hair cell mechanotransducer channels are required for aminoglycoside ototoxicity.

Authors:  Abdelrahman Alharazneh; Lauren Luk; Markus Huth; Ashkan Monfared; Peter S Steyger; Alan G Cheng; Anthony J Ricci
Journal:  PLoS One       Date:  2011-07-26       Impact factor: 3.240

Review 3.  Using the zebrafish lateral line to uncover novel mechanisms of action and prevention in drug-induced hair cell death.

Authors:  Tamara M Stawicki; Robert Esterberg; Dale W Hailey; David W Raible; Edwin W Rubel
Journal:  Front Cell Neurosci       Date:  2015-02-18       Impact factor: 5.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.